Filteren op Last updated date SelecterenNaVoorFrom - To Datum Einddatum Deze week Deze maand Afgelopen week Afgelopen maand Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationResearch and developmentMedicine shortagesBiosimilarsSMEAntimicrobial resistanceGovernanceBrexitQuality of medicinesCorporateGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationMedical devicesScientific adviceMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorParallel distributionProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety Yes Laat dit veld leeg Filter Resultaten (3786) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Laat dit veld leeg EMA welcomes new Head of International Affairs 1 oktober 2021 News Corporate Careers Governance Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 27-30 September 2021 1 oktober 2021 News Human COVID-19 Pharmacovigilance EMA starts review of meningioma risk with nomegestrol- and chlormadinone-containing medicines 1 oktober 2021 News Human Pharmacovigilance Referrals Transatlantic Taskforce continues international fight against antimicrobial resistance 30 september 2021 News Human Veterinary Antimicrobial resistance Clinical trials EMA implements new measures to minimise animal testing during medicines development 29 september 2021 News Human Veterinary Corporate Innovation EMA evaluating data on booster dose of COVID-19 vaccine Spikevax 27 september 2021 News Human COVID-19 Medicines Call for expressions of interest for civil society representatives to participate in work of Committee for Advanced Therapies 24 september 2021 News Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 30 August – 2 September 2021 17 september 2021 News Human COVID-19 Pharmacovigilance Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 13-16 September 2021 17 september 2021 News Human COVID-19 Medicines Referrals New add-on treatment for rare autoimmune inflammatory disorder 17 september 2021 News Human Medicines 1 … 53 54 55 56 57 Page 57 of 379 58 59 60 61 … 379
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 27-30 September 2021 1 oktober 2021 News Human COVID-19 Pharmacovigilance
EMA starts review of meningioma risk with nomegestrol- and chlormadinone-containing medicines 1 oktober 2021 News Human Pharmacovigilance Referrals
Transatlantic Taskforce continues international fight against antimicrobial resistance 30 september 2021 News Human Veterinary Antimicrobial resistance Clinical trials
EMA implements new measures to minimise animal testing during medicines development 29 september 2021 News Human Veterinary Corporate Innovation
EMA evaluating data on booster dose of COVID-19 vaccine Spikevax 27 september 2021 News Human COVID-19 Medicines
Call for expressions of interest for civil society representatives to participate in work of Committee for Advanced Therapies 24 september 2021 News
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 30 August – 2 September 2021 17 september 2021 News Human COVID-19 Pharmacovigilance
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 13-16 September 2021 17 september 2021 News Human COVID-19 Medicines Referrals
New add-on treatment for rare autoimmune inflammatory disorder 17 september 2021 News Human Medicines